281 related articles for article (PubMed ID: 28726720)
21. RBM5/H37 tumor suppressor, located at the lung cancer hot spot 3p21.3, alters expression of genes involved in metastasis.
Oh JJ; Taschereau EO; Koegel AK; Ginther CL; Rotow JK; Isfahani KZ; Slamon DJ
Lung Cancer; 2010 Dec; 70(3):253-62. PubMed ID: 20338664
[TBL] [Abstract][Full Text] [Related]
22. Transforming growth factor-β 1 enhances the invasiveness of breast cancer cells by inducing a Smad2-dependent epithelial-to-mesenchymal transition.
Lv ZD; Kong B; Li JG; Qu HL; Wang XG; Cao WH; Liu XY; Wang Y; Yang ZC; Xu HM; Wang HB
Oncol Rep; 2013 Jan; 29(1):219-25. PubMed ID: 23129177
[TBL] [Abstract][Full Text] [Related]
23. Silencing of transforming growth factor-beta1 in situ by RNA interference for breast cancer: implications for proliferation and migration in vitro and metastasis in vivo.
Moore LD; Isayeva T; Siegal GP; Ponnazhagan S
Clin Cancer Res; 2008 Aug; 14(15):4961-70. PubMed ID: 18676771
[TBL] [Abstract][Full Text] [Related]
24. ARF1 controls Rac1 signaling to regulate migration of MDA-MB-231 invasive breast cancer cells.
Lewis-Saravalli S; Campbell S; Claing A
Cell Signal; 2013 Sep; 25(9):1813-9. PubMed ID: 23707487
[TBL] [Abstract][Full Text] [Related]
25. Study of events leading cellular senescence to human mammary epithelial cancer cells in vitro.
Saxena S; Jain AK; Bhatnagar D
Indian J Cancer; 2001; 38(2-4):103-16. PubMed ID: 12593448
[TBL] [Abstract][Full Text] [Related]
26. The role of Rac1 in maintaining malignant phenotype of mouse skin tumor cells.
Kwei KA; Finch JS; Ranger-Moore J; Bowden GT
Cancer Lett; 2006 Jan; 231(2):326-38. PubMed ID: 15893875
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta1 treatment leads to an epithelial-mesenchymal transdifferentiation of pancreatic cancer cells requiring extracellular signal-regulated kinase 2 activation.
Ellenrieder V; Hendler SF; Boeck W; Seufferlein T; Menke A; Ruhland C; Adler G; Gress TM
Cancer Res; 2001 May; 61(10):4222-8. PubMed ID: 11358848
[TBL] [Abstract][Full Text] [Related]
28. RAC1 GTP-ase signals Wnt-beta-catenin pathway mediated integrin-directed metastasis-associated tumor cell phenotypes in triple negative breast cancers.
De P; Carlson JH; Jepperson T; Willis S; Leyland-Jones B; Dey N
Oncotarget; 2017 Jan; 8(2):3072-3103. PubMed ID: 27902969
[TBL] [Abstract][Full Text] [Related]
29. Soluble MMP-14 produced by bone marrow-derived stromal cells sheds epithelial endoglin modulating the migratory properties of human breast cancer cells.
Tobar N; Avalos MC; Méndez N; Smith PC; Bernabeu C; Quintanilla M; Martínez J
Carcinogenesis; 2014 Aug; 35(8):1770-9. PubMed ID: 24618373
[TBL] [Abstract][Full Text] [Related]
30. Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b.
Schnelzer A; Prechtel D; Knaus U; Dehne K; Gerhard M; Graeff H; Harbeck N; Schmitt M; Lengyel E
Oncogene; 2000 Jun; 19(26):3013-20. PubMed ID: 10871853
[TBL] [Abstract][Full Text] [Related]
31. TGF-beta-mediated cell cycle arrest of HPV16-immortalized human ectocervical cells correlates with decreased E6/E7 mRNA and increased p53 and p21(WAF-1) expression.
Rorke EA; Zhang D; Choo CK; Eckert RL; Jacobberger JW
Exp Cell Res; 2000 Aug; 259(1):149-57. PubMed ID: 10942587
[TBL] [Abstract][Full Text] [Related]
32. Down-regulation of cyclin-dependent kinase-4 and MAPK through estrogen receptor mediated cell cycle arrest in human breast cancer induced by gold nanoparticle tagged toxin protein NKCT1.
Bhowmik T; Gomes A
Chem Biol Interact; 2017 Apr; 268():119-128. PubMed ID: 28322778
[TBL] [Abstract][Full Text] [Related]
33. Expression of tumor-related Rac1b antagonizes B-Raf-induced senescence in colorectal cells.
Henriques AF; Barros P; Moyer MP; Matos P; Jordan P
Cancer Lett; 2015 Dec; 369(2):368-75. PubMed ID: 26341689
[TBL] [Abstract][Full Text] [Related]
34. Negative Control of Cell Migration by Rac1b in Highly Metastatic Pancreatic Cancer Cells Is Mediated by Sequential Induction of Nonactivated Smad3 and Biglycan.
Otterbein H; Lehnert H; Ungefroren H
Cancers (Basel); 2019 Dec; 11(12):. PubMed ID: 31817656
[TBL] [Abstract][Full Text] [Related]
35. Human pituitary tumor-transforming gene 1 overexpression reinforces oncogene-induced senescence through CXCR2/p21 signaling in breast cancer cells.
Ruan JW; Liao YC; Lua I; Li MH; Hsu CY; Chen JH
Breast Cancer Res; 2012 Jul; 14(4):R106. PubMed ID: 22789011
[TBL] [Abstract][Full Text] [Related]
36. A novel function for p21Cip1 and acetyltransferase p/CAF as critical transcriptional regulators of TGFβ-mediated breast cancer cell migration and invasion.
Dai M; Al-Odaini AA; Arakelian A; Rabbani SA; Ali S; Lebrun JJ
Breast Cancer Res; 2012 Sep; 14(5):R127. PubMed ID: 22995475
[TBL] [Abstract][Full Text] [Related]
37. BMP4 inhibits the proliferation of breast cancer cells and induces an MMP-dependent migratory phenotype in MDA-MB-231 cells in 3D environment.
Ampuja M; Jokimäki R; Juuti-Uusitalo K; Rodriguez-Martinez A; Alarmo EL; Kallioniemi A
BMC Cancer; 2013 Sep; 13():429. PubMed ID: 24053318
[TBL] [Abstract][Full Text] [Related]
38. RAC1B Regulation of
Ungefroren H; Otterbein H; Wellner UF; Keck T; Lehnert H; Marquardt JU
Cancers (Basel); 2020 Nov; 12(12):. PubMed ID: 33260366
[TBL] [Abstract][Full Text] [Related]
39. Deferoxamine-induced increase in the intracellular iron levels in highly aggressive breast cancer cells leads to increased cell migration by enhancing TNF-α-dependent NF-κB signaling and TGF-β signaling.
Liu P; He K; Song H; Ma Z; Yin W; Xu LX
J Inorg Biochem; 2016 Jul; 160():40-8. PubMed ID: 27138103
[TBL] [Abstract][Full Text] [Related]
40. RAC1B: A Rho GTPase with Versatile Functions in Malignant Transformation and Tumor Progression.
Melzer C; Hass R; Lehnert H; Ungefroren H
Cells; 2019 Jan; 8(1):. PubMed ID: 30621237
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
